Cladis Investment Advisory, LLC Pfizer Inc Transaction History

Cladis Investment Advisory, LLC

$144 Billion
Q3 2024

A detailed history of Cladis Investment Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 58,138 shares of PFE stock, worth $1.54 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

58,138

Previous 56,910 2.16%

Holding current value

$1.54 Million

Previous $1.59 Billion 5.66%

% of portfolio

1.17%

Previous 1.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $34,015 - $38,546	1,228 Added 2.16%	58,138 $1.68 Billion
Q2 2024 Oct 09, 2024	BUY	$25.26 - $29.6 $32,888 - $38,539	1,302 Added 2.34%	56,910 $1.59 Billion
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $32,888 - $38,539	1,302 Added 2.57%	51,910 $1.45 Million
Q1 2024 Oct 09, 2024	BUY	$25.89 - $29.73 $95,741 - $109,941	3,698 Added 7.12%	55,608 $1.54 Billion
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $199,430 - $229,010	7,703 Added 17.95%	50,608 $1.4 Million
Q4 2023 Oct 09, 2024	BUY	$26.13 - $33.94 $167,022 - $216,944	6,392 Added 15.4%	47,905 $1.38 Billion
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $167,022 - $216,944	6,392 Added 17.51%	42,905 $1.24 Million
Q3 2023 Oct 09, 2024	SELL	$32.09 - $37.51 $333,639 - $389,991	-10,397 Reduced 20.03%	41,513 $1.38 Billion
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $8,792 - $10,277	-274 Reduced 0.74%	36,513 $1.21 Million
Q2 2023 Oct 09, 2024	SELL	$36.12 - $41.79 $18,710 - $21,647	-518 Reduced 1.22%	41,787 $1.53 Billion
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $18,710 - $21,647	-518 Reduced 1.39%	36,787 $1.35 Million
Q1 2023 Oct 09, 2024	SELL	$39.39 - $51.28 $378,340 - $492,544	-9,605 Reduced 18.5%	42,305 $1.73 Billion
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $3,466 - $4,512	-88 Reduced 0.24%	37,305 $1.52 Million
Q4 2022 Oct 09, 2024	SELL	$41.75 - $54.5 $20,791 - $27,141	-498 Reduced 1.16%	42,393 $2.17 Billion
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $20,791 - $27,141	-498 Reduced 1.31%	37,393 $1.92 Million
Q3 2022 Oct 09, 2024	SELL	$43.76 - $53.42 $394,671 - $481,794	-9,019 Reduced 17.37%	42,891 $1.88 Billion
Q3 2022 Nov 17, 2022	SELL	$43.76 - $53.42 $30,194 - $36,859	-690 Reduced 1.79%	37,891 $1.66 Million
Q2 2022 Oct 09, 2024	SELL	$46.53 - $55.17 $387,548 - $459,510	-8,329 Reduced 16.05%	43,581 $2.28 Billion
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $111,625 - $132,352	-2,399 Reduced 5.85%	38,581 $2.02 Million
Q1 2022 Oct 08, 2024	SELL	$45.75 - $56.69 $11,391 - $14,115	-249 Reduced 0.54%	45,980 $2.38 Billion
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $11,391 - $14,115	-249 Reduced 0.6%	40,980 $2.12 Million
Q4 2021 Oct 08, 2024	SELL	$41.32 - $61.25 $234,738 - $347,961	-5,681 Reduced 10.94%	46,229 $2.73 Billion
Q4 2021 Oct 01, 2024	SELL	$41.32 - $61.25 $234,738 - $347,961	-5,681 Reduced 10.94%	46,229 $2.43 Billion
Q4 2021 May 10, 2022	BUY	$41.32 - $61.25 $1.7 Million - $2.53 Million	41,229 New	41,229 $2.44 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.

Account

Cladis Investment Advisory, LLC Pfizer Inc Transaction History